PHC Holdings Corporation Stock

Equities

6523

JP3801300009

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange 08:26:54 2024-04-25 pm EDT 5-day change 1st Jan Change
1,120 JPY -0.36% Intraday chart for PHC Holdings Corporation +1.45% -22.20%
Sales 2024 * 349B 2.24B Sales 2025 * 349B 2.24B Capitalization 142B 910M
Net income 2024 * -6.66B -42.78M Net income 2025 * 9.75B 62.66M EV / Sales 2024 * 1.04 x
Net Debt 2024 * 221B 1.42B Net Debt 2025 * 198B 1.27B EV / Sales 2025 * 0.97 x
P/E ratio 2024 *
-21.3 x
P/E ratio 2025 *
14.5 x
Employees 9,403
Yield 2024 *
6.41%
Yield 2025 *
4.8%
Free-Float 21.51%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.53%
1 week+1.45%
Current month-9.55%
1 month-15.24%
3 months-27.07%
6 months-20.65%
Current year-22.20%
More quotes
1 week
1 114.00
Extreme 1114
1 147.00
1 month
1 081.00
Extreme 1081
1 336.00
Current year
1 081.00
Extreme 1081
1 549.00
1 year
1 081.00
Extreme 1081
1 650.00
3 years
1 081.00
Extreme 1081
3 120.00
5 years
1 081.00
Extreme 1081
3 120.00
10 years
1 081.00
Extreme 1081
3 120.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 21-05-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 21-05-31
Director/Board Member 62 21-09-02
Director/Board Member 63 13-07-31
More insiders
Date Price Change Volume
24-04-25 1,120 -0.36% 35 300
24-04-25 1,124 -0.79% 158,500
24-04-24 1,133 +0.18% 280,100
24-04-23 1,131 -0.62% 219,400
24-04-22 1,138 +3.27% 330,000

Delayed Quote Japan Exchange, April 25, 2024 at 08:26 pm EDT

More quotes
PHC Holdings Corp is a Japan-based company mainly engaged in the development, manufacture and sale of healthcare devices and services. The Company operates through three business segments. The Diabetes Management segment is involved in the development, manufacture and sale of in vitro diagnostic equipment such as self-monitoring blood glucose systems and point-of-care testing (POCT) products and electric drug injectors. The Healthcare Solutions segment is involved in the development and sale of medical information technology (IT) products such as receipt computers and electronic medical records, as well as the development of clinical laboratory diagnosis business. The Diagnostic and Life Science segment is involved in the development, manufacture and sale of research and medical support equipment, pathological diagnosis equipment, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
7
Last Close Price
1,124 JPY
Average target price
1,200 JPY
Spread / Average Target
+6.76%
Consensus